Emergent BioSolutions (EBS) Treasury Shares (2012 - 2026)

Emergent BioSolutions' Treasury Shares history runs 15 years deep, the most recent figure standing at $261.6 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 14.89% year-over-year to $261.6 million in Q1 2026; TTM through Mar 2026 was $261.6 million, a 14.89% increase from a year earlier, with the FY2025 full-year figure at $252.6 million, up 10.94% from the prior year.
• Treasury Shares rose to $261.6 million in Q1 2026 per EBS's latest filing, from $252.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $9.6 million in Q1 2026 and bottomed at $4.9 million in Q1 2022.
• The 5-year median for Treasury Shares is $5.6 million (2022), against an average of $6.2 million.
• Across the five-year window, Treasury Shares surged 475.0% in 2022 and changed 0.0% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $227.7 million in 2022, then changed by 0.0% to $227.7 million in 2023, then changed by 0.0% to $227.7 million in 2024, then advanced by 10.94% to $252.6 million in 2025, then grew by 3.56% to $261.6 million in 2026.
• Per Business Quant, the three latest EBS Treasury Shares figures stand at $261.6 million (Q1 2026), $252.6 million (Q4 2025), and $243.5 million (Q3 2025).